The Chemours
CC
13.98
-0.10
-0.71%
The Chemours
US · CC
#2748 by market cap
Listed 1970
13.98
-0.10
-0.71%
Live - 5344 symbols - heartbeat 369s ago
· 2026-10-08 04:01
Pre-market
13.96
-0.14%
After-hours
13.98
0.00%
Overnight
13.98
0.00%
- Market cap
- 2.10B
- P/E (TTM)i
- -6.92
- P/Bi
- -42.88
- EPSi
- -2.57
- Div yieldi
- 2.50%
- 52W posi
- 20%
Reader sentiment
Are you bullish or bearish on CC?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 8 analysts
Buy
Avg price target
18.71 +33.8%
Price target rangecurrent 13.98
Low16.00
Avg18.71
High22.00
Buy 63%
Hold 38%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-05 | UBS | -- | HOLD | 16.00 |
| 2026-10-05 | BMO Capital | -- | BUY | 18.00 |
| 2026-09-30 | Mizuho Securities | -- | BUY | 18.00 |
| 2026-09-23 | Mizuho Securities | -- | BUY | 20.00 |
| 2026-09-11 | Truist Financial | -- | BUY | -- |
| 2026-08-24 | UBS | -- | HOLD | -- |
| 2026-08-24 | Goldman Sachs | -- | HOLD | 17.00 |
| 2026-08-19 | Alembic Global | -- | BUY | 22.00 |
| 2026-08-13 | BMO Capital | -- | BUY | 18.00 |
| 2026-08-10 | UBS | -- | HOLD | 18.00 |
| 2026-08-10 | Morgan Stanley | -- | HOLD | 18.00 |
| 2026-08-06 | Truist Financial | -- | BUY | 24.00 |
| 2026-08-05 | Mizuho Securities | -- | BUY | 22.00 |
| 2026-08-05 | Morgan Stanley | -- | HOLD | 21.00 |
| 2026-08-05 | RBC Capital | -- | BUY | 22.00 |
| 2026-08-04 | BMO Capital | -- | BUY | 26.00 |
| 2026-08-04 | Goldman Sachs | -- | HOLD | 19.00 |
| 2026-07-22 | Goldman Sachs | -- | HOLD | 19.00 |
| 2026-07-06 | BMO Capital | -- | BUY | 26.00 |
| 2026-07-01 | Mizuho Securities | -- | BUY | 25.00 |
| 2026-06-30 | RBC Capital | -- | BUY | 26.00 |
| 2026-06-17 | Truist Financial | -- | BUY | -- |
| 2026-05-13 | Alembic Global | -- | BUY | 30.00 |
| 2026-05-08 | UBS | -- | BUY | 30.00 |
| 2026-05-08 | RBC Capital | -- | BUY | 29.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 0 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: UBS moved from Buy to Hold on 2026-08-10.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-08-10 | UBS | BUY → HOLD | 18.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-04 | After close | ±10.72% | -18.63% (beat) |
| 2026/Q1 | 2026-05-05 | After close | ±12.27% | -15.28% (beat) |
| 2025/Q4 | 2026-02-19 | After close | ±12.14% | -16.51% (beat) |
| 2025/Q3 | 2025-11-06 | After close | ±13.82% | +6.56% (in line) |
| 2025/Q2 | 2025-08-05 | After close | ±12.19% | -4.99% (in line) |
| 2025/Q1 | 2025-05-06 | After close | ±11.97% | -9.92% (in line) |
| 2024/Q4 | 2025-02-18 | -- | ±11.46% | +3.86% (in line) |
| 2024/Q3 | 2024-11-04 | -- | ±10.92% | +15.49% (beat) |
| 2024/Q2 | 2024-08-01 | After close | ±10.02% | -11.88% (beat) |
| 2024/Q1 | 2024-04-30 | After close | ±7.06% | -2.80% (in line) |
| 2023/Q4 | 2024-03-27 | After close | ±9.20% | -9.07% (in line) |
| 2023/Q3 | 2023-10-26 | After close | ±7.67% | -2.72% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 04:01:03 · For reference only, not investment advice and not tailored to your situation.